Search
Please choose your country
more info

Contact:
Phone:+49 0761 1514 440 Fax:+49 0761 1514 460 Email: info@falkfoundation.org

Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

Falk Gastro Review Journal

This page provides access to all FGR publications selected from international medical journals since mid-2022. You may browse the 1000+ articles by using one of the organ- or indication-related filters below or select all articles from a specific issue. If you are looking for ta specific journal edition, please have a look at the FGR print version. 

Esophagus to Small Intestine

Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected celiac disease without IgA deficiency (Bi.A.CeD): A multicenter, prospective cohort study

Lancet Gastroenterol Hepatol. 2023;8(11):1005–14

Ciacci C, Bai JC, Holmes G, Al-Toma A, Biagi F, Carroccio A, Ciccocioppo R, Di Sabatino A, Gingold-Belfer R, Jinga M, Makharia G, Niveloni S, Norman GL, Rostami K, Sanders DS, Smecuol E, Villanacci V, Vivas S, Zingone F; Bi.A.CeD study group

Esophagus to Small Intestine

Persistent villous atrophy predicts development of complications and mortality in adult patients with celiac disease: A multicenter longitudinal cohort study and development of a score to identify high-risk patients

Gut. 2023;72(11):2095–102

Schiepatti A, Maimaris S, Raju SA, Green OL, Mantica G, Therrien A, Flores-Marin D, Linden J, Fernández-Bañares F, Esteve M, Leffler D, Biagi F, Sanders DS

Esophagus to Small Intestine

Psychological processes, not physiological parameters, are most important contributors to symptom severity in patients with refractory heartburn/regurgitation symptoms

Gastroenterology. 2023;165(4):848–60

Guadagnoli L, Geeraerts A, Geysen H, Pauwels A, Vanuytsel T, Tack J, Van Oudenhove L

Esophagus to Small Intestine

Bismuth quadruple three-in-one single capsule 3 times a day increases effectiveness compared with the usual 4 times a day schedule: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Gut. 2023;72(11):2031–7

Pérez-Aisa Á, Nyssen OP, Keco-Huerga A, Rodrigo L, Lucendo AJ, Gomez-Rodriguez BJ, Ortuño J, Perona M, Huguet JM, Núñez O, Fernandez-Salazar L, Barrio J, Lanas A, Iyo E, Romero PM, Fernández-Bermejo M, Gomez B, Garre A, Gomez-Camarero J, Lamuela LJ, Campillo A, de la Peña-Negro L, Dominguez Cajal M, Bujanda L, Burgos-Santamaría D, Bermejo F, González-Carrera V, Pajares R, Almela Notari P, Tejedor-Tejada J, Planella M, Jiménez I, Arguedas Lázaro Y, Cuadrado-Lavín A, Pérez-Martínez I, Amorena E, Gonzalez-Santiago JM, Angueira T, Flores V, Martínez-Domínguez SJ, Pabón-Carrasco M, Velayos B, Algaba A, Ramírez C, Alfaro Almajano E, Castro-Fernandez M, Alcaide N, Sanz Segura P, Cano-Català A, García-Morales N, Moreira L, Mégraud F, O’Morain C, Calvet X, Gisbert JP

Esophagus to Small Intestine

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic esophagitis (LIBERTY EoE TREET study): A multicenter, double-blind, randomized, placebo-controlled, phase 3 trial

Lancet Gastroenterol Hepatol. 2023;8(11):990–1004

Rothenberg ME, Dellon ES, Collins MH, Hirano I, Chehade M, Bredenoord AJ, Lucendo AJ, Spergel JM, Sun X, Hamilton JD, Mortensen E, Laws E, Maloney J, Mannent LP, McCann E, Liu X, Glotfelty L, Shabbir A

Esophagus to Small Intestine

Epidemiologic burden and projections for eosinophilic esophagitis-associated emergency department visits in the United States: 2009–2030

Clin Gastroenterol Hepatol. 2023;21(12):3041–50.e3

Lam AY, Lee JK, Coward S, Kaplan GG, Dellon ES, Bredenoord AJ, Jairath V, Crowley E, Gupta M, Jijon H, Nasser Y, Andrews CN, Chehade M, Gonsalves N, Hirano I, Ma C

Esophagus to Small Intestine

Mepolizumab for treatment of adolescents and adults with eosinophilic esophagitis: A multicenter, randomized, double-blind, placebo-controlled clinical trial

Gut. 2023;72(10):1828–37

Dellon ES, Peterson KA, Mitlyng BL, Iuga A, Bookhout CE, Cortright LM, Walker KB, Gee TS, McGee SJ, Cameron BA, Galanko JA, Woosley JT, Eluri S, Moist SE, Hirano I

Esophagus to Small Intestine

Comparison of drugs for active eosinophilic esophagitis: Systematic review and network meta-analysis

Gut. 2023;72(11):2019–30

Visaggi P, Barberio B, Del Corso G, de Bortoli N, Black CJ, Ford AC, Savarino E

Esophagus to Small Intestine

Non-erosive gastroesophageal reflux disease and incidence of esophageal adenocarcinoma in 3 Nordic countries: Population-based cohort study

BMJ. 2023;382:e076017

Holmberg D, Santoni G, von Euler-Chelpin M, Färkkilä M, Kauppila JH, Maret-Ouda J, Ness-Jensen E, Lagergren J